Kenya will participate in final clinical trials for a coronavirus vaccine being developed by AstraZeneca and Oxford University. It will be the second African country to be involved in the trials that were suspended on Wednesday after a participant had a suspected adverse reaction in the UK. At least 400 healthcare workers will take part in the Kenyan trials that will be conducted in two coastal towns of Mombasa and Kilifi.
